Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Transtarget Inc
Profile last edited on: 11/28/17      CAGE: 7BZA4      UEI: ZK1CMJHQMGM6

Business Identifier: Novel approaches to cell-based therapies for cancer
Year Founded
2015
First Award
2016
Latest Award
2018
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1230 Bordeaux Drive
Sunnyvale, CA 94089
   (408) 747-5201
   N/A
   N/A
Location: Single
Congr. District: 17
County: Santa Clara

Public Profile

A start-up initiated, housed in Panorama Research facilities and managed by highly experienced ppersonnel from that organization, TransTarget is addressing development of new approaches to cell-based treatments for cancer.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$449,533
Phase II Dollars
$0
Total Awarded
$449,533

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2018 1 NIH $224,624
Project Title: Multifunctional Antibody Therapy for Acute Myocardial Infarction
2016 1 NIH $224,909
Project Title: Novel Stem Cell Therapy for Acute Myocardial Infarction in Diabetes Mellitus

Key People / Management

  Manley Huang -- Director, Immunology

  James W Larrick -- President and Co-founder

  Jianming Wang

  Jianming Wang

Company News

There are no news available.